Asset Comparison and Correlation
|SK Innovation vs PSUS THERAPEUTIC|
Assuming 30 trading days horizon, SK Innovation is expected to generate 0.29 times more return on investment than CYNAF. However, SK Innovation is 3.45 times less risky than CYNAF. It trades about 0.21 of its potential returns per unit of risk. CYNAF is currently generating about -0.32 per unit of risk. If you would invest 14,200,000 in SK Innovation on April 21, 2013 and sell it today you would earn a total of 1,200,000 from holding SK Innovation or generate 8.45% return on investment over 30 days.
89% of all equities and portfolios perform better than SK Innovation. Compared with the overall equity markets, risk-adjusted returns on investments in SK Innovation are ranked lower than 11 (%) of all global equities and portfolios over the last 30 days.
Match ups for SK Innovati
Over the last 30 days CYNAF has generated negative risk-adjusted returns adding no value to investors with long positions.
Match ups for CYNAF